Emd Serono Research & Development Institute, Inc.

This large study aimed to see if adding an experimental drug called Xevinapant to standard chemoradiation treatment could better control locally advanced head and neck cancer and help patients live longer without the cancer returning. It involved 730 adults with newly diagnosed, …

This study tested whether adding an experimental drug called xevinapant to standard radiotherapy could better prevent cancer from returning in people with high-risk head and neck cancer who had surgery. It focused on patients who could not safely take the usual high-dose chemothe…

This early-stage study aimed to test the safety of a new drug called M9466 when combined with standard chemotherapy for advanced solid tumors and colorectal cancer. The trial was designed for people whose cancer had progressed despite standard treatments. However, the study was t…

This early-stage study tested whether adding an experimental drug called xevinapant to standard chemotherapy and radiation was safe for people with advanced head and neck cancer. The trial enrolled 18 participants who had not received prior treatment for their cancer. Researchers…